CD8A and neoplasm: Cross-presentation of OVA-derived peptide to major histocompatibility complex-1 (MHC-I) was increased in CD103+ and CD8+ DCs from tumour-draining LNs and CD103+ DCs from tumours of Y27632-treated mice (Fig. 4h and Supplementary Fig. 13).